Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Women who have gestational diabetes mellitus (GDM) have elevated lifetime risks for the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), compared with their peers. However, it is not known whether their risk of CVD is dependent upon the development of T2DM. Thus, we sought to evaluate the role of T2DM in determining vascular outcomes in women with previous GDM. RESEARCH DESIGN AND METHODS: All women in Ontario, Canada, with a live-birth pregnancy between April 1994 and March 2014 (n = 1,515,079) were stratified into the following four groups: women with GDM in whom T2DM subsequently developed (n = 15,585, median age 32 years); those with GDM in whom T2DM did not develop (n = 41,299; median age 32 years); women who did not have GDM but in whom T2DM developed (n = 49,397; median age 31 years); and those with neither GDM nor T2DM (n = 1,408,798; median age 30 years). Women were followed over a median time of 10.0 years for the development of microvascular and macrovascular outcomes. RESULTS: Among women who had GDM, only those in whom T2DM developed had an increased risk of vitrectomy/photocoagulation (hazard ratio [HR] 4.49, 95% CI 3.90–5.17), renal dialysis (HR 7.52, 5.24–10.81), and hospitalization for foot infection (HR 4.32, 3.42–5.46) (all P < 0.0001). However, for macrovascular outcomes, both women with GDM in whom T2DM developed and those in whom T2DM did not develop had increased risks of CVD (HR 2.82; 2.41–3.30; P < 0.0001; and HR 1.30; 1.07–1.59; P = 0.008, respectively) and coronary artery disease (HR 3.54; 2.96–4.23; P < 0.0001; and HR 1.41; 1.11–1.80; P = 0.005, respectively), although absolute event rates were very low. CONCLUSIONS: Women with GDM have an elevated risk of cardiovascular outcomes, even in the absence of T2DM. In contrast, microvascular risk emerges only in those in whom T2DM develops.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women with a history of GDM are at an increased risk of developing type 2 diabetes mellitus (T2DM) postpartum and also have a significantly higher risk of developing a metabolic syndrome and cardiovascular diseases compared to women with normal glucose tolerance (NGT) in pregnancy [2,3].”
Citations
Cites
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“fold higher incidence of T2DM, compared with their peers (1).”
BackgroundBuchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Hux, J. E., Ivis, F., Flintoft, V., & Bica, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.512 · Cited by 1,290 · cited 1×
“The Ontario Diabetes Database (ODD) is a validated registry of physician-diagnosed nongestational diabetes mellitus that is derived using these data (18).”
BackgroundIncreased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489 · cited 1×
“In an earlier study involving 8,191 women with GDM and 81,262 control subjects, adjustment for the development of T2DM attenuated the relationship between GDM and subsequent CVD, leading to the suggestion that intervening T2DM drives the enhanced cardiovascular risk observed in this population (15).”
ResultSelf-citationCarr, D. B., Utzschneider, K. M., Hull, R. L., Tong, J., Wallace, T. M., Kodama, K., Shofer, J. B., Heckbert, S. R., Boyko, E. J., Fujimoto, W. Y., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2482 · Cited by 350
Lauenborg, J., Mathiesen, E., Hansen, T., Glümer, C., Jørgensen, T., Borch-Johnsen, K., Hornnes, P., Pedersen, O., & Damm, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1713 · Cited by 279
Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J. G., & Zinman, B. (2008) · Diabetes Care · doi:10.2337/dc08-0972 · Cited by 251 · cited 1×
“As the incidence of impaired glucose tolerance (IGT) is known to be much higher in womenwith previous GDM than in their peers (8,21), it is possible that the po-”
BackgroundSelf-citationRetnakaran, R., & Shah, B. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090569 · Cited by 194
Self-citationGlucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Zinman, B., & Hanley, A. J. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1990 · Cited by 190 · cited 1×
“postpartum (24,28,29), suggesting a chronicity that could provide sufficient duration of exposure to contribute to atherosclerosis.”
BackgroundSelf-citationMetabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087863 · Cited by 163
Research works printed but not linked: 1
- Kralji, 2000, Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario, Ont Med Rev, 67, 33
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Kramer, C. K., Campbell, S., & Retnakaran, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4840-2 · Cited by 965
Self-citationTobias, D. K., Stuart, J. J., Li, S., Chavarro, J., Rimm, E. B., Rich-Edwards, J., Hu, F. B., Manson, J. E., & Zhang, C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2790 · Cited by 323
Li, Z., Cheng, Y., Wang, D., Chen, H., Chen, H., Ming, W.-K., & Wang, Z. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3076463 · Cited by 231
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 208
Metadata
- Authors
- Retnakaran, R., & Shah, B. R.
- Affiliations
- Mount Sinai Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Shah, Baiju R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-07
- Volume
- 40
- Issue
- 1
- Pages
- 101-108
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553073169
- Cited by
- 167
- References
- 33
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 15 · 2023: 16 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 20 · 2018: 19 · 2017: 10
- FWCI
- 21.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, type 2 diabetes, cardiovascular disease, diabetic retinopathy, diabetic nephropathy, dialysis, foot infection, coronary artery disease, microvascular complications, macrovascular complications, women, diabetes risk stratification, live birth, hospitalization, vitrectomy, photocoagulation, coronary angiography
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Kidney Diseases, Ontario, Pregnancy, Retinal Diseases, Risk Factors, Time Factors, Proportional Hazards Models, Case-Control Studies, Diabetes, Gestational, Postpartum Period, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus. https://app.cochat.ai/papers/10.2337/dc16-1400
- The paper
- Retnakaran, R., & Shah, B. R. (2017). Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus. Diabetes Care. https://doi.org/10.2337/dc16-1400
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.